Cutler Group LP Regenxbio Inc. Transaction History
Cutler Group LP
- $307 Million
- Q1 2024
A detailed history of Cutler Group LP transactions in Regenxbio Inc. stock. As of the latest transaction made, Cutler Group LP holds 2,100 shares of RGNX stock, worth $28,644. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,100
Previous 1,300
61.54%
Holding current value
$28,644
Previous $4,000
50.0%
% of portfolio
0.0%
Previous 0.0%
Shares
21 transactions
Others Institutions Holding RGNX
# of Institutions
192Shares Held
42.6MCall Options Held
80.6KPut Options Held
55.2K-
Black Rock Inc. New York, NY7.6MShares$104 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.88MShares$66.5 Million0.0% of portfolio
-
Redmile Group, LLC San Francisco, CA4.55MShares$62.1 Million3.78% of portfolio
-
Jpmorgan Chase & CO New York, NY3.72MShares$50.8 Million0.01% of portfolio
-
State Street Corp Boston, MA3.12MShares$42.6 Million0.0% of portfolio
About REGENXBIO Inc.
- Ticker RGNX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 43,230,000
- Market Cap $590M
- Description
- REGENXBIO Inc., a clinical-stage biotechnology company, provides gene therapy product candidates to deliver genes to cells to address genetic defects or to enable cells in the body to produce therapeutic proteins or antibodies that are intended to impact disease. Its gene therapy product candidates are based on NAV Technology Platform, a proprie...